- Cervix Cancer in Sub-Saharan Africa JCO Global Oncology 2020
- Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy
This is a study by Aba Scott and her colleagues Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. The study sought to demonstrate the feasibility of treating cervical cancer patients with MRI-guided brachytherapy (MRgBT) using 24 Gy in 3 fractions (F) versus a standard, a more resource-intensive regimen of 28 Gy in 4F, and its ability to meet EMBRACE II planning aims. The study found that a less-resource intense fractionation schedule of 24 Gy/3Fis an alternative to 28 Gy/4F in cervix MRgBT.